(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

USO DE UM RECEPTOR 2 DE PEPTÍDEO FORMILA / AGONISTA DE RECEPTOR A4 LIPOXINA (FPR2/ALX) PARA TRATAMENTO DE INSUFICIÊNCIA CARDÍACA

ArquivadaInvention PatentPCT · US2018033783

Application data

Number

112019024185

Type

Invention Patent

Filing

05/22/2018

Publication

06/02/2020

PCT

US2018033783

Progress at the INPI

  1. Filing05/22/18
  2. Publication06/02/20
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: the INPI technical office action was not answered in time (art. 36 of the Brazilian IP Act). The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 01/10/2023. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

BRISTOL-MYERS SQUIBB COMPANY

US

See this company's full portfolio

Inventors

J. O. (pessoa física)

US

N. C. (pessoa física)

US

N. W. (pessoa física)

US

R. G. (pessoa física)

US

Technical data

Priority claims

US

62/509,489 · 05/22/2017

Abstract

A presente invenção refere-se genericamente a métodos de tratamento de insuficiência cardíaca com Composto 1,1-((3S,4R)-4-(2,6-diflúor-4-metoxifenil)-2-oxopirrolidin-3-il)-3-fenilureia.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento - Art. 36 §1° da LPI

#11.2

01/10/2023

RPI 2714

Parecer de pré-exame

#6.23

09/20/2022

RPI 2698

Adição na publicação

#15.35

10/19/2021

RPI 2650

Notificação de entrada na fase nacional - PCT

#1.3

06/02/2020

RPI 2578

Alteração de dados cadastrais

#1.1

11/26/2019

RPI 2551

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.